TRAWS PHARMA(TRAW),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TRAW TRAWS PHARMA

Trading 08-28 15:44:15 EDT

0.5870

+0.0016

+0.27%

High0.6000	Low0.5800	Vol39.38K
Open0.6000	D1 Closing0.5854	Amplitude3.42%
Mkt Cap9.02M	Tradable Cap7.15M	Total Shares15.37M
T/O23.25K	T/O Rate0.32%	Tradable Shares12.18M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":0.587,"timestamp":1787946000277,"preClose":0.5854,"halted":0,"volume":39383,"delay":0,"changeRate":0.002733173898189161,"floatShares":12179546,"shares":15368277,"eps":-1.473278,"marketStatus":"Trading","change":0.0016,"latestTime":"08-28 15:44:15 EDT","open":0.6,"high":0.6,"low":0.58,"amount":23251.759826190002,"amplitude":0.034165,"askPrice":0.5899,"askSize":400,"bidPrice":0.5841,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.473278,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787947200000},"marketStatusCode":2,"adr":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":0.5854,"preHourTrading":{"tag":"盘前","latestPrice":0.59,"preClose":0.5854,"latestTime":"08:43 EDT","volume":15,"amount":8.85,"timestamp":1787921038908,"change":0.0046,"changeRate":0.007858,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":0.5534,"preClose":0.5854,"latestTime":"19:30 EDT","volume":1622,"amount":920.3411,"timestamp":1787873403818,"change":-0.032,"changeRate":-0.054663,"amplitude":0.07465},"volumeRatio":0.343266,"impliedVol":1.6331,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/TRAW/wiki","defaultTab":"wiki","newsList":[{"id":"2660464174","title":"Traws Pharma Price Target Maintained with a $1.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660464174","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660464174?lang=en_us&edition=fundamental","pubTime":"2026-08-18 19:44","pubTimestamp":1787053440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRAW/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660696174","title":"Analysts Offer Insights on Healthcare Companies: Invivyd (IVVD), Traws Pharma (TRAW) and DocGo (DCGO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660696174","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660696174?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:20","pubTimestamp":1787048425,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Invivyd (IVVD), Traws Pharma (TRAW) and DocGo (DCG...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-invivyd-ivvd-traws-pharma-traw-and-docgo-dcgo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-invivyd-ivvd-traws-pharma-traw-and-docgo-dcgo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4007","TRAW","XLV","IVVD","DCGO","LABU","XBI","BK4581","LU0029874061.USD","LU0128526141.USD","BK4137","BK4539","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659795121","title":"Traws Pharma Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659795121","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659795121?lang=en_us&edition=fundamental","pubTime":"2026-08-15 05:08","pubTimestamp":1786741712,"startTime":"0","endTime":"0","summary":"Traws Pharma Inc reports results for the quarter ended June 30 - Earnings SummaryTraws Pharma IncTRAW.OQreported a quarterly adjusted loss of 25 cents per share for the quarter ended June 30.  The mea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B1M3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659512115","title":"Traws Pharma Q2 EPS $(0.16) Beats $(0.34) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659512115","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659512115?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:56","pubTimestamp":1786740984,"startTime":"0","endTime":"0","summary":"Traws Pharma (NASDAQ:TRAW) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.34) by 51.52 percent. This is a 45.45 percent decrease over losses of $(0.11) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61230920/traws-pharma-q2-eps-0-16-beats-0-34-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Traws Pharma Q2 EPS $(0.16) Beats $(0.34) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659899121","title":"Traws Pharma Q2 Revenue Falls to Zero on Licensing Termination; Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2659899121","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659899121?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:40","pubTimestamp":1786740022,"startTime":"0","endTime":"0","summary":"Traws Pharma Q2 revenue falls to zero on licensing termination; net loss widensOverviewUS biopharmaceutical firm's Q2 revenue fell to zero from prior yr due to licensing terminationNet loss for Q2 wid","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MBRX","TRAW","BK4139","BK4007","ATRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659544121","title":"Traws Pharma - no Revenue Recognized for Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2659544121","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659544121?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:30","pubTimestamp":1786739401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLX1BCTZ3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129447","title":"Traws Pharma Inc Q2 Net Income USD -3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129447?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:30","pubTimestamp":1786739401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLX1BCTZ3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129444","title":"Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129444?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:30","pubTimestamp":1786739400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA9YFM8R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939063","title":"Traws Pharma Inc Expected to Post a Loss of 34 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939063","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658939063?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:01","pubTimestamp":1786366864,"startTime":"0","endTime":"0","summary":"Traws Pharma Inc <TRAW.OQ> expected to post a loss of34cents a share - Earnings PreviewTraws Pharma IncTRAW.OQTRAW.Ois expected to  report resultson August 12  for the period ending June 30 2026LSEG's mean analyst estimate for Traws Pharma Inc is for a loss of 34 cents per share.The current average analyst rating on the shares is \"hold\" and the breakdown of recommendations is no \"strong buy\" or \"buy,\" 2 \"hold\" and no \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for Traws Pharma Inc is $1.00, about 88% above its last closing price of $0.53This summary was machine generated August 10 at 13:01 GMT.  All figures in US dollars unless otherwise stated.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N44711P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656656303","title":"TRAW Moves TRX-100 Through Early Human Testing: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2656656303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656656303?lang=en_us&edition=fundamental","pubTime":"2026-08-04 00:31","pubTimestamp":1785774692,"startTime":"0","endTime":"0","summary":"Traws Pharma, Inc. ($TRAW) announced an update on their ongoing clinical study. Traws Pharma, Inc. (TRAW) is running a Phase 1 study called “A Rand...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/traw-moves-trx-100-through-early-human-testing-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/traw-moves-trx-100-through-early-human-testing-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","ISBC","BK4007","TRX","BK4017","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656439914","title":"Traws Pharma Risks NASDAQ Delisting After Shares Trade Below $1 for 30 Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2656439914","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656439914?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:17","pubTimestamp":1785529050,"startTime":"0","endTime":"0","summary":"Traws Pharma risks Nasdaq delisting after shares trade below $1 for 30 daysTraws Pharma received a Nasdaq notice on July 29, 2026 for failing the $1 minimum bid price rule on Nasdaq Capital Market.Non","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL5JbvvN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650132243","title":"Traws Pharma Launches At-the-market Offering of up to $5.58 Million in Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2650132243","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650132243?lang=en_us&edition=fundamental","pubTime":"2026-07-11 04:04","pubTimestamp":1783713859,"startTime":"0","endTime":"0","summary":"Traws Pharma launches at-the-market offering of up to $5.58 million in sharesTraws Pharma set up an at-the-market equity program with Citizens JMP Securities to sell common stock.Program size capped a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL4s1jgx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974393","title":"Traws Pharma Holds Annual Shareholder Meeting in Virtual Format","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974393","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974393?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:02","pubTimestamp":1783627321,"startTime":"0","endTime":"0","summary":"Traws Pharma holds annual shareholder meeting in virtual formatTraws Pharma held its annual shareholder meeting on July 8, 2026.Shareholders adopted an amendment to the 2021 Incentive Compensation Pla","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL6vlGQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648526574","title":"Traws Pharma files $139.19M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2648526574","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648526574?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:05","pubTimestamp":1782936319,"startTime":"0","endTime":"0","summary":"16:03 EDT Traws Pharma (TRAW) files $139.19M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/traws-pharma-files-139-19m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/traws-pharma-files-139-19m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648952541","title":"Traws Pharma Inc Files for Mixed Shelf Offering of up to $139.2 Mln - Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648952541","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648952541?lang=en_us&edition=fundamental","pubTime":"2026-07-02 04:03","pubTimestamp":1782936211,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nFWN4330Z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645022306","title":"Traws Pharma Says Updated Toxicology Data Being Developed on Influenza Prophylaxis Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645022306","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645022306?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:23","pubTimestamp":1782131035,"startTime":"0","endTime":"0","summary":"Traws Pharma  said Monday it has started developing an updated toxicology data package for the planned phase 2a human influenza challenge study of tivoxavir marboxil in response to information requirements from the UK's Medicines and Healthcare Products Regulatory Agency.Traws said it expects to resubmit the updated data package to the MHRA during Q3 to enable the human challenge study to proceed and provide proof of concept data for the use of tivoxavir marboxil as an oral prophylaxis medicine.The company said it expects a formal response from the regulator within 30 days of the resubmission.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645021030","title":"BRIEF-Traws Pharma Provides Updated Guidance On Influenza Prophylaxis Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2645021030","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645021030?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:46","pubTimestamp":1782128812,"startTime":"0","endTime":"0","summary":"BRIEF-Traws Pharma Provides Updated Guidance On Influenza Prophylaxis ProgramJune 22 (Reuters) - Traws Pharma Inc TRAW.O:TRAWS PHARMA PROVIDES UPDATED GUIDANCE ON INFLUENZA PROPHYLAXIS PROGRAMTRAWS PH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029139","title":"Traws Pharma targets 3Q 2026 MHRA resubmission to advance TXM Phase 2a influenza challenge study","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029139","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029139?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:02","pubTimestamp":1782126127,"startTime":"0","endTime":"0","summary":"Traws Pharma outlined plans to resubmit an updated toxicology package to the UK MHRA in 3Q 2026 for tivoxavir marboxil.The filing targets clearance to start a Phase 2a human seasonal influenza challenge study in healthy volunteers; no clinical results have been presented.Management expects the updated package to address MHRA requirements, aiming to keep the prophylaxis program moving toward proof-of-concept readouts.MHRA feedback prompted additional preclinical safety work; a formal agency response is expected within 30 days of resubmission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Traws Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval sy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL4DjcB0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645674029","title":"Traws Pharma - Preparing Updated Toxicology Data for Mhra Tivoxavir Marboxil Phase 2a Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2645674029","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645674029?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TRAW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645602964","title":"Traws Pharma - Company Expects Mhra Response Within 30 Days of Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2645602964","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645602964?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:00","pubTimestamp":1782126028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nFWN42S085:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TRAW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.trawspharma.com","stockEarnings":[{"period":"1week","weight":0.1258},{"period":"1month","weight":0.1411},{"period":"3month","weight":-0.599},{"period":"6month","weight":-0.6452},{"period":"1year","weight":-0.5877},{"period":"ytd","weight":-0.4819}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0193},{"period":"6month","weight":0.1241},{"period":"1year","weight":0.1925},{"period":"ytd","weight":0.1308}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.179894},{"month":2,"riseRate":0.384615,"avgChangeRate":-0.08728},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.040526},{"month":4,"riseRate":0.230769,"avgChangeRate":-0.139367},{"month":5,"riseRate":0.384615,"avgChangeRate":-0.053691},{"month":6,"riseRate":0.692308,"avgChangeRate":0.029769},{"month":7,"riseRate":0.230769,"avgChangeRate":-0.053841},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.090069},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.103896},{"month":10,"riseRate":0.230769,"avgChangeRate":-0.080722},{"month":11,"riseRate":0.461538,"avgChangeRate":-0.058331},{"month":12,"riseRate":0.307692,"avgChangeRate":0.009577}],"exchange":"NASDAQ","name":"TRAWS PHARMA","nameEN":"TRAWS PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TRAWS PHARMA(TRAW),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TRAWS PHARMA(TRAW) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TRAWS PHARMA,TRAW,TRAWS PHARMA股票,TRAWS PHARMA股票老虎,TRAWS PHARMA股票老虎国际,TRAWS PHARMA行情,TRAWS PHARMA股票行情,TRAWS PHARMA股价,TRAWS PHARMA股市,TRAWS PHARMA股票价格,TRAWS PHARMA股票交易,TRAWS PHARMA股票购买,TRAWS PHARMA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TRAWS PHARMA(TRAW),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TRAWS PHARMA(TRAW) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}